However, by activating the BCR through ligands such as calreticulin and vimentin, the MSCs cause aberrant canonical NF-κB activity in the CLL cell, promoting survival and proliferation (47). Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.